Luminex 200 RUO System w /xPONENT 4.3 from R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(1) Exploration of the induced cytokine responses in European Lyme neuroborreliosis: A longitudinal cohort studyTicks and tick-borne diseasesJanuary 1, 2023Gynthersen RMM, Ørbæk M, Mens H, Stenør C, Wiese L, Ostrowski SR, Nielsen SD, Lebech AM.

(2) Molecular Biomarkers of Prognosis in Advanced Renal Cell Carcinoma Patients Treated With Pazopanib Plus Interferon Alpha (INF-2A) in a Phase I/II Study by the Spanish Oncology Genitourinary GroupClinical genitourinary cancerAugust 1, 2022García-Del-Muro X, Durán I, Perez-Gracia JL, Ángel Climent M, Mellado B, Virizuela JA, Castellano DE, González Del Alba A, García Carbonero I, Álvarez-Fernández C, et al.

(4) Lipocalin 2 modulates dendritic cell activity and shapes immunity to influenza in a microbiome dependent mannerPLoS pathogensApril 1, 2021Watzenboeck ML, Drobits B, Zahalka S, Gorki AD, Farhat A, Quattrone F, Hladik A, Lakovits K, Richard GM, Lederer T, et al.

(5) HPV58 E7 Protein Expression Profile in Cervical Cancer and CIN with ImmunohistochemistryJournal of CancerJanuary 1, 2021Zheng Q, Chen X, Han R, Zhu J, Wang H, Chen L, Song Y, Chen L, Cheng H, Jin N.

(6) Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case reportNature communicationsDecember 14, 2020Buckland MS, Galloway JB, Fhogartaigh CN, Meredith L, Provine NM, Bloor S, Ogbe A, Zelek WM, Smielewska A, Yakovleva A, et al.

(8) Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)Journal of ovarian researchMarch 5, 2020Farkas B, Boldizsar F, Bohonyi N, Farkas N, Marczi S, Kovacs GL, Bodis J, Koppan M.

Luminex 200 RUO System w /xPONENT 4.3